Adriana Estrada‐Bernal

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair”.

Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair

Nucleic Acids Research(2021)10.1093/nar/gkab871

N/A

0.644DataRank · unranked

72 citations

Changxian Shen, Adriana Estrada‐Bernal, Ryan Robb, Moumita Chatterjee, Nikhil Sebastian +6 more

Novel Human-Derived RET Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling

Molecular Pharmacology(2021)10.1124/molpharm.120.000207

N/A

0.360DataRank · unranked

10 citations

Anh T. Le, Adriana Estrada‐Bernal, Andrea E. Doak, Minjae Yoo, Sarah E. Ferrara +6 more

Data from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

(2023)10.1158/1078-0432.c.6529985

N/A

0DataRank · unranked

0 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

Data from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

(2023)10.1158/1078-0432.c.6529985.v1

N/A

0DataRank · unranked

0 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment

Nature Communications(2025)10.1038/s41467-025-58568-x

N/A

0DataRank · unranked

15 citations

Eva-Maria Hansbauer, Thomas J. Jaquin, J. Peper-Gabriel, Poornima Mahavadi, Mark E. Snyder +28 more

Supplementary Figure S3 from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

(2023)10.1158/1078-0432.22478576

N/A

0DataRank · unranked

0 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3555

N/A

0DataRank · unranked

81 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more